Home LiteratureArticle Details
PMID: 23992479 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.

American journal of respiratory and critical care medicine ·Vol. 188 ·No. 10 ·2013-11-15 ·Pages 1224-31

Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WO, Moffatt MF, Johnston SL

Abstract

Rhinovirus infection is followed by significantly increased frequencies of positive, potentially pathogenic sputum cultures in chronic obstructive pulmonary disease (COPD). However, it remains unclear whether these represent de novo infections or an increased load of organisms from the complex microbial communities (microbiome) in the lower airways. To investigate the effect of rhinovirus infection on the airway bacterial microbiome. Subjects with COPD (n = 14) and healthy control subjects with normal lung function (n = 17) were infected with rhinovirus. Induced sputum was collected at baseline before rhinovirus inoculation and again on Days 5, 15, and 42 after rhinovirus infection and DNA was extracted. The V3-V5 region of the bacterial 16S ribosomal RNA gene was amplified and pyrosequenced, resulting in 370,849 high-quality reads from 112 of the possible 124 time points. At 15 days after rhinovirus infection, there was a sixfold increase in 16S copy number (P = 0.007) and a 16% rise in numbers of proteobacterial sequences, most notably in potentially pathogenic Haemophilus influenzae (P = 2.7 × 10(-20)), from a preexisting community. These changes occurred only in the sputum microbiome of subjects with COPD and were still evident 42 days after infection. This was in contrast to the temporal stability demonstrated in the microbiome of healthy smokers and nonsmokers. After rhinovirus infection, there is a rise in bacterial burden and a significant outgrowth of Haemophilus influenzae from the existing microbiota of subjects with COPD. This is not observed in healthy individuals. Our findings suggest that rhinovirus infection in COPD alters the respiratory microbiome and may precipitate secondary bacterial infections.

MeSH Terms
Aged Case-Control Studies DNA, Bacterial/analysis Disease Progression Female Genetic Markers Humans Male Microbiota Middle Aged Phylogeny Picornaviridae Infections/complications,microbiology Prospective Studies Pulmonary Disease, Chronic Obstructive/complications,microbiology,virology RNA, Ribosomal, 16S/analysis Rhinovirus Sequence Analysis, DNA Sputum/microbiology
Chemicals
DNA, Bacterial Genetic Markers RNA, Ribosomal, 16S
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Molyneaux Philip L
1 National Heart and Lung Institute, Imperial College, London, United Kingdom.
Mallia Patrick
Cox Michael J
Footitt Joseph
Willis-Owen Saffron A G
Homola Daniel
Trujillo-Torralbo Maria-Belen
Elkin Sarah
Kon Onn Min
Cookson William O C
Moffatt Miriam F
Johnston Sebastian L
References (40)
40 references, click to expand
  1. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons.
    Genome Res. 2011 Mar;21(3):494-504 PMID: 21212162
  2. UniFrac--an online tool for comparing microbial community diversity in a phylogenetic context.
    BMC Bioinformatics. 2006 Aug 07;7:371 PMID: 16893466
  3. Chronic obstructive pulmonary disease: a growing but neglected global epidemic.
    PLoS Med. 2007 May;4(5):e112 PMID: 17503959
  4. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.
    Am J Respir Crit Care Med. 2012 Sep 15;186(6):536-45 PMID: 22798321
  5. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.
    N Engl J Med. 2002 Aug 15;347(7):465-71 PMID: 12181400
  6. Disordered microbial communities in asthmatic airways.
    PLoS One. 2010 Jan 05;5(1):e8578 PMID: 20052417
  7. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
    Arch Intern Med. 2005 Apr 25;165(8):891-7 PMID: 15851640
  8. Analysis of the lung microbiome in the "healthy" smoker and in COPD.
    PLoS One. 2011 Feb 22;6(2):e16384 PMID: 21364979
  9. Statistical methods for detecting differentially abundant features in clinical metagenomic samples.
    PLoS Comput Biol. 2009 Apr;5(4):e1000352 PMID: 19360128
  10. Phylogenetic relationships of Thiomicrospira species and their identification in deep-sea hydrothermal vent samples by denaturing gradient gel electrophoresis of 16S rDNA fragments.
    Arch Microbiol. 1995 Sep;164(3):165-72 PMID: 7545384
  11. Defective phagocytosis in airways disease.
    Chest. 2012 Apr;141(4):1055-1062 PMID: 22474147
  12. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.
    Am J Respir Crit Care Med. 2011 Mar 15;183(6):734-42 PMID: 20889904
  13. Cellular mechanisms of mainstream cigarette smoke-induced lung epithelial tight junction permeability changes in vitro.
    Inhal Toxicol. 2007 Jan;19(1):13-22 PMID: 17127639
  14. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats.
    Annu Rev Microbiol. 1985;39:321-46 PMID: 3904603
  15. Rhinovirus enhances various bacterial adhesions to nasal epithelial cells simultaneously.
    Laryngoscope. 2009 Jul;119(7):1406-11 PMID: 19434681
  16. Comparison of the respiratory microbiome in healthy nonsmokers and smokers.
    Am J Respir Crit Care Med. 2013 May 15;187(10):1067-75 PMID: 23491408
  17. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations.
    OMICS. 2010 Feb;14(1):9-59 PMID: 20141328
  18. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut.
    Appl Environ Microbiol. 1999 Nov;65(11):4799-807 PMID: 10543789
  19. Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers.
    Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):630-4 PMID: 7881648
  20. Lung microbiology and exacerbations in COPD.
    Int J Chron Obstruct Pulmon Dis. 2012;7:555-69 PMID: 22969296
  21. Decade-long bacterial community dynamics in cystic fibrosis airways.
    Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5809-14 PMID: 22451929
  22. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy.
    Appl Environ Microbiol. 2007 Aug;73(16):5261-7 PMID: 17586664
  23. Significance of the microbiome in obstructive lung disease.
    Thorax. 2012 May;67(5):456-63 PMID: 22318161
  24. Search and clustering orders of magnitude faster than BLAST.
    Bioinformatics. 2010 Oct 1;26(19):2460-1 PMID: 20709691
  25. Recent advances in exacerbations of COPD.
    Thorax. 2008 Oct;63(10):850-2 PMID: 18820113
  26. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.
    Thorax. 2002 Oct;57(10):847-52 PMID: 12324669
  27. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 2006 May 1;173(9):991-8 PMID: 16474030
  28. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
    Am J Respir Crit Care Med. 2006 May 15;173(10):1114-21 PMID: 16484677
  29. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 2012 Dec 1;186(11):1117-24 PMID: 23024024
  30. Upper airways microbiota in antibiotic-naïve wheezing and healthy infants from the tropics of rural Ecuador.
    PLoS One. 2012;7(10):e46803 PMID: 23071640
  31. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review.
    Respirology. 2010 Apr;15(3):536-42 PMID: 20415983
  32. Topographical continuity of bacterial populations in the healthy human respiratory tract.
    Am J Respir Crit Care Med. 2011 Oct 15;184(8):957-63 PMID: 21680950
  33. The lung tissue microbiome in chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 2012 May 15;185(10):1073-80 PMID: 22427533
  34. Oral immunotherapy with inactivated nontypeable Haemophilus influenzae reduces severity of acute exacerbations in severe COPD.
    Chest. 2010 Apr;137(4):805-11 PMID: 19952063
  35. An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study.
    Respir Res. 2006 Sep 06;7:116 PMID: 16956406
  36. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA.
    Appl Environ Microbiol. 1993 Mar;59(3):695-700 PMID: 7683183
  37. PyNAST: a flexible tool for aligning sequences to a template alignment.
    Bioinformatics. 2010 Jan 15;26(2):266-7 PMID: 19914921
  38. Accurate determination of microbial diversity from 454 pyrosequencing data.
    Nat Methods. 2009 Sep;6(9):639-41 PMID: 19668203
  39. QIIME allows analysis of high-throughput community sequencing data.
    Nat Methods. 2010 May;7(5):335-6 PMID: 20383131
  40. The influence of sex, handedness, and washing on the diversity of hand surface bacteria.
    Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17994-9 PMID: 19004758
Article Info
Journal
American journal of respiratory and critical care medicine
Abbr.
Am J Respir Crit Care Med
ISSN
1535-4970
Published
2013-11-15
Pages
1224-31
Language
English
Region
United States
NLM ID
9421642
PMCID
PMC3863728
Subset
IM
Grants
Medical Research Council · G1000758 · United Kingdom
Wellcome Trust · 083567/Z/07/Z · United Kingdom
Medical Research Council · G0600879 · United Kingdom
Wellcome Trust · 097117 · United Kingdom
Wellcome Trust · United Kingdom
Wellcome Trust · 096964/Z/11/Z · United Kingdom
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com